Blood coagulation detector may help in monitoring stroke risk

Blood coagulation detector may help in monitoring stroke risk
Assessing embolic stroke risk by measuring blood coagulability. Credit: Department of Biofunctional Informatics, TMDU

Atrial fibrillation (AF) causes an irregular and sometimes fast heart rate, and is a common risk factor for stroke. To estimate this risk in AF patients and determine the requirement for anticoagulation therapy, the CHADS2 predictive score is used. Because some parts of this score are also associated with atherosclerosis risk and increased blood coagulability, a high score has been proposed as linked to hypercoagulability (an increased tendency for blood clotting) in both AF and non-AF patients. However, this association has not been fully investigated, partly owing to the lack of a sensitive means of detection.

A research team from TMDU used a highly sensitive technique to measure small changes in blood coagulation, and found hypercoagulability in non-AF with high CHADS2 scores. The study was recently reported in PLOS ONE.

Several physical and chemical factors affect blood clotting, some of which can be measured over time to determine blood coagulability and the likelihood of clot formation. Dielectric blood coagulometry (DBCM) is a recently developed test that measures changes in the dielectric permittivity of whole blood, representing clumping of red blood cells. The researchers used DBCM to detect changes in the dielectric permittivity of whole blood at 10 MHz. Comparisons between untreated blood and that with added heparin (a blood thinner) or tissue factor (a -clotting accelerator) enabled derivation of a coagulability index.

Blood coagulation detector may help in monitoring stroke risk
A new index calculated from dielectric coagulometer. Credit: Department of Biofunctional Informatics

"We calculated the end of acceleration time (EAT) as an index of coagulability from temporal changes in dielectric permittivity," coauthor Satomi Hamada says. "This value reduced when tissue factor was added, and increased with heparin present. It was also sensitive enough to detect small changes in coagulability, particularly in hypercoagulability." EAT also boasts high reproducibility and reliability.

The researchers found that patients receiving warfarin had a significantly longer EAT than those without, confirming the anticoagulation effect. They also showed that patients with a high CHADS2 score had a significantly shorter EAT that represented hypercoagulability compared with patients with lower CHADS2 scores. "Intriguingly, EAT varied widely in patients with CHADS2 scores of 0 or 1," lead author Yuki Hasegawa says. "This suggests that DBCM can identify high risk of thrombosis even in patients with low CHADS2 scores."


Explore further

CHADS2 best predictor of postoperative mortality risk

More information: Yuki Hasegawa et al, Novel Dielectric Coagulometer Identifies Hypercoagulability in Patients with a High CHADS2 Score without Atrial Fibrillation, PLOS ONE (2016). DOI: 10.1371/journal.pone.0156557
Journal information: PLoS ONE

Provided by Tokyo Medical and Dental University
Citation: Blood coagulation detector may help in monitoring stroke risk (2016, July 1) retrieved 15 December 2019 from https://medicalxpress.com/news/2016-07-blood-coagulation-detector.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments